Gene Expression in Oligodendroglial Tumors
Background: Oligodendroglial tumors with 1p/19q loss are more likely to be chemosensitive and have longer survival than those with intact 1p/19q, but not all respond to chemotherapy, warranting investigation of the biological basis of chemosensitivity.
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.3233/ACP-CLO-2010-0533 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832565848562204672 |
|---|---|
| author | Elisabeth J. Shaw Brian Haylock David Husband Daniel du Plessis D. Ross Sibson Peter C. Warnke Carol Walker |
| author_facet | Elisabeth J. Shaw Brian Haylock David Husband Daniel du Plessis D. Ross Sibson Peter C. Warnke Carol Walker |
| author_sort | Elisabeth J. Shaw |
| collection | DOAJ |
| description | Background: Oligodendroglial tumors with 1p/19q loss are more likely to be chemosensitive and have longer survival than those with intact 1p/19q, but not all respond to chemotherapy, warranting investigation of the biological basis of chemosensitivity. |
| format | Article |
| id | doaj-art-3956c6b428aa4d5796083b26cd4cde45 |
| institution | Kabale University |
| issn | 2210-7177 2210-7185 |
| language | English |
| publishDate | 2010-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Analytical Cellular Pathology |
| spelling | doaj-art-3956c6b428aa4d5796083b26cd4cde452025-02-03T01:06:21ZengWileyAnalytical Cellular Pathology2210-71772210-71852010-01-01332819410.3233/ACP-CLO-2010-0533Gene Expression in Oligodendroglial TumorsElisabeth J. Shaw0Brian Haylock1David Husband2Daniel du Plessis3D. Ross Sibson4Peter C. Warnke5Carol Walker6School of Cancer Studies, University of Liverpool, Liverpool, UKClatterbridge Centre for Oncology, Clatterbridge Hospital, Bebington, Wirral, UKClatterbridge Centre for Oncology, Clatterbridge Hospital, Bebington, Wirral, UKSalford Royal Hospital and Clinical Neurosciences Research Group, University of Manchester, Manchester, UKSchool of Cancer Studies, University of Liverpool, Liverpool, UKDepartment of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USASchool of Cancer Studies, University of Liverpool, Liverpool, UKBackground: Oligodendroglial tumors with 1p/19q loss are more likely to be chemosensitive and have longer survival than those with intact 1p/19q, but not all respond to chemotherapy, warranting investigation of the biological basis of chemosensitivity.http://dx.doi.org/10.3233/ACP-CLO-2010-0533 |
| spellingShingle | Elisabeth J. Shaw Brian Haylock David Husband Daniel du Plessis D. Ross Sibson Peter C. Warnke Carol Walker Gene Expression in Oligodendroglial Tumors Analytical Cellular Pathology |
| title | Gene Expression in Oligodendroglial Tumors |
| title_full | Gene Expression in Oligodendroglial Tumors |
| title_fullStr | Gene Expression in Oligodendroglial Tumors |
| title_full_unstemmed | Gene Expression in Oligodendroglial Tumors |
| title_short | Gene Expression in Oligodendroglial Tumors |
| title_sort | gene expression in oligodendroglial tumors |
| url | http://dx.doi.org/10.3233/ACP-CLO-2010-0533 |
| work_keys_str_mv | AT elisabethjshaw geneexpressioninoligodendroglialtumors AT brianhaylock geneexpressioninoligodendroglialtumors AT davidhusband geneexpressioninoligodendroglialtumors AT danielduplessis geneexpressioninoligodendroglialtumors AT drosssibson geneexpressioninoligodendroglialtumors AT petercwarnke geneexpressioninoligodendroglialtumors AT carolwalker geneexpressioninoligodendroglialtumors |